Human medicines European public assessment report (EPAR): Bavencio, avelumab, Neuroendocrine Tumors, Date of authoris...

Human medicines European public assessment report (EPAR): Bavencio, avelumab, Neuroendocrine Tumors, Date of authorisation: 18/09/2017, Revision: 9, Status: Authorised Human medicines European public assessment report (EPAR): Bavencio, avelumab, Neuroendocrine Tumors, Date of authorisation: 18/09/2017, Revision: 9, Status: Authorised Samen in Beweging LIVE at #WHS2021 with @DrTedros: WHO Council on the Economics of #HealthForAll

Actueel zorgnieuws in jouw mailbox ontvangen?

Direct het hele artikel lezen? Meld je aan voor de nieuwsbrief.